Bausch Health adds former FDA commissioner to board — 3 insights

Bausch Health appointed Andrew C. von Eschenbach, MD, to its board of directors.

Advertisement

Here’s what you should know:

1. Dr. von Eschenbach began serving as the board’s director Oct. 29.

2. Bausch Health has 11 members on its board. Ten are independent.

3. Bausch Health Chairman and CEO Joseph Papa said, “Andy’s multiple roles throughout his distinguished career, ranging from his service as commissioner of the U.S. Food and Drug Administration and as director of the National Cancer Institute to his more than 25 years at the University of Texas MD Anderson Cancer Center, make him an invaluable addition to the board.”

More articles on supply chain: 
Physicians Endoscopy partners with 3 ASCs — 3 insights
Dr. Nicholas Grosso: Don’t forget about private practice — 4 insights
Hitting the sweet spot: 7 statistics on the ideal number of physician owners for ASCs

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply chain

Advertisement

Comments are closed.